Singapore markets closed

Tasly Pharmaceutical Group Co., Ltd (600535.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
12.56-0.35 (-2.71%)
At close: 03:00PM CST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
1,101,698
1,071,072
-264,238
2,358,865
1,125,891
-
Depreciation & amortisation
-
504,911
517,952
487,767
539,673
-
Change in working capital
-
642,123
524,192
1,278,040
30,489
-
Inventory
-
-220,722
-2,860
-198,368
56,579
-
Other working capital
1,551,233
1,906,816
1,875,274
2,229,435
1,382,355
-
Other non-cash items
-
58,504
81,203
85,347
335,028
-
Net cash provided by operating activities
-
2,575,635
2,279,684
2,801,160
1,791,167
-
Cash flows from investing activities
Investments in property, plant and equipment
-537,127
-668,819
-404,410
-571,725
-408,812
-
Acquisitions, net
-
-
-
-147,309
-
-481.364
Purchases of investments
-562,154
-1,782,892
-3,870,623
-1,508,908
-4,599,934
-
Sales/maturities of investments
1,232,284
1,679,923
3,012,465
1,692,083
4,729,160
-
Other investing activities
-
-1,337,961
-4,856
-85.4021
405,138
-
Net cash used for investing activities
-1,204,141
-2,108,558
-1,266,081
-42,835
865,858
-
Net change in cash
-435,371
-730,538
807,364
276,974
334,162
-
Cash at beginning of period
2,679,416
2,927,871
2,120,507
1,827,517
1,493,355
-
Cash at end of period
2,241,673
2,197,333
2,927,871
2,104,491
1,827,517
-
Free cash flow
Operating cash flow
-
2,575,635
2,279,684
2,801,160
1,791,167
-
Capital expenditure
-537,127
-668,819
-404,410
-571,725
-408,812
-
Free cash flow
1,551,233
1,906,816
1,875,274
2,229,435
1,382,355
-